Results 121 to 130 of about 1,182,900 (211)

<i>In Vitro</i> Testing of Ibrutinib-Loaded Electrospun Nanofibers for Potential Use as a Transdermal Patch Material. [PDF]

ACS Omega
Fil H, Yesiltepe O, Er Zeybekler S, Kozgus O, Kurbanoglu S, Medine EI, Odaci D.   +6 more
europepmc   +1 more source

A comprehensive battery of flow cytometric immunoassays for the in vitro testing of chemical effects in human blood cells. [PDF]

Front Immunol, 2023
Pierzchalski A, Zenclussen AC, Herberth G.   +2 more
europepmc   +1 more source

3D printed aligner materials: <i>In vitro</i> testing of biocompatibility, cytotoxicity and antimicrobial activity. [PDF]

Bioinformation
Rajagopal A, Budda KS, Binmuhana NO, Seshagiri R, Shaik MS, Bhogi S.   +5 more
europepmc   +1 more source

In vitro testing of a funnel-tip catheter with different clot types to decrease clot migration in mechanical thrombectomy. [PDF]

Interv Neuroradiol, 2023
Payne ES, Krost-Reuhl S, Heimann A, Keric N, Masomi-Bornwasser J, Gerber T, Seidman L, Kirschner S, Brockmann MA, Tanyildizi Y.   +9 more
europepmc   +1 more source

Optimizing stent retrievers for mechanical enhancement and in vitro testing in acute ischemic stroke models. [PDF]

Biomed Eng Online
Lee JW, Kim HK, Kim J, Choi H.
europepmc   +1 more source

Translating the Manufacture of Immunotherapeutic PLGA Nanoparticles from Lab to Industrial Scale: Process Transfer and In Vitro Testing. [PDF]

Pharmaceutics, 2022
Operti MC, Bernhardt A, Pots J, Sincari V, Jager E, Grimm S, Engel A, Benedikt A, Hrubý M, De Vries IJM, Figdor CG, Tagit O.   +11 more
europepmc   +1 more source

Black-blood MRI at 7T using 2D RARE MRI: In vitro testing and in vivo demonstration. [PDF]

Z Med Phys
Peschke E, Pravdivtseva MS, Jansen O, Larsen N, Hövener JB.   +4 more
europepmc   +1 more source

Novel <i>N</i>-Alkyl 3-(3-Benzyloxyquinoxalin-2-yl) Propanamides as Antiproliferative Agents: Design, Synthesis, In Vitro Testing, and In Silico Mechanistic Study. [PDF]

Molecules
Abubshait SA.
europepmc   +1 more source

Recommendations from the COST action CA17116 (SPRINT) for the standardization of perinatal derivative preparation and in vitro testing. [PDF]

Front Bioeng Biotechnol, 2023
Janev A, Banerjee A, Weidinger A, Dimec J, Leskošek B, Silini AR, Cirman T, Wolbank S, Ramuta TŽ, Jerman UD, Pandolfi A, Di Pietro R, Pozzobon M, Giebel B, Eissner G, Ferk P, Lang-Olip I, Alviano F, Soritau O, Parolini O, Kreft ME.   +20 more
europepmc   +1 more source

A Novel Approach for In Vitro Testing and Hazard Evaluation of Nanoformulated RyR2-Targeting siRNA Drugs Using Human PBMCs. [PDF]

Life (Basel)
Bettinsoli V, Melzi G, Crea A, Degli Esposti L, Iafisco M, Catalucci D, Ciana P, Corsini E.   +7 more
europepmc   +1 more source